AMNIOCORD® is a dehydrated human umbilical cord allograft that provides a protective environment to support the healing process. It is comprised of an extracellular matrix of hyaluronic acid and collagen.

AMNIOCORD Product Benefits

As a primary component in the umbilical cord, natural HA hydrates and reinforces collagen, forming a reinforced matrix to support the wound healing cascade.

Protective Environment

AMNIOCORD provides a protective environment to support the healing process.

Regulatory Proteins

AMNIOCORD provides a human biocompatible extracellular matrix of hyaluronic acid and collagen and contains 250+ regulatory proteins.1,2

Product Advantages

  • Human-derived
  • Thick graft allows for suturing to keep the graft in place and for placement in deeper surgical sites*
  • Supports challenging closures in comorbid patients
  • Simple storage and application
  • Compatible with negative pressure wound therapy (NPWT) and hyperbaric oxygen therapy (HBOT)

Clinical Use Examples

AMNIOCORD has been used across a wide range of surgical applications including:


  • Debridement
  • Surgical wounds
  • Dehiscence repair
  • Tendon & ligament repair
  • Bunionectomies
  • Rotator cuff repair
  • Limb salvage
  • Amputations
  • Diabetic Foot Ulcers (DFUs)
  • Venous Leg Ulcers (VLUs)
  • Smaller or deeper surgical sites
  • Tendon, bone, or hardware coverage
  • When graft fixation is desired*

    *Not intended for use as a load bearing tissue.

    Making a Difference

    AMNIOCORD Processing & Details

    AMNIOCORD is processed using PURION, a unique patented method for placental-based allografts that is in accordance with the American Association of Tissue Banks (AATB) standards. The product is derived from placental tissue donated by healthy, consenting mothers who have given live Caesarean section birth in the US.

    MIMEDX’s patented PURION process preserves extracellular matrix components, including regulatory factors and other matrix-associated proteins. For an additional level of safety, the product is terminally sterilized.

    1. MIMEDX Internal Report. MM-RD-00086, Proteome Characterization of PURION Processed Dehydrated Human Amnion Chorion Membrane (dHACM) and PURION PLUS Processed Dehydrated Human Umbilical Cord (dHUC) Allografts.
    2. Bullard JD, Lei J, Lim JJ, Massee M, Fallon AM, Koob TJ. Evaluation of dehydrated human umbilical cord biological properties for wound care and soft tissue healing. J Biomed Mater Res B Appl Biomater. 2019;107(4):1035-1046.


    Product Brochure

    MIMEDX Advantage

    We improve people’s health and lives through innovation that delivers solutions for patients and caregivers. With a wide variety of allograft configurations, clinicians can choose the product that best meets their treatment objectives.

    Healthcare Professionals

    MIMEDX offers unique value to clinicians across sites of care. With a broad support system, we offer services to support needs relating to reimbursement and coverage, product access and cost containment, education, patient information, and clinical applications.

    Our Products

    Click the toggle below to view our product solutions by: